Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Colorectal Cancer

How do patients outside the screening population fare?

    • Gastroenterology and Hepatology
    • News
    • Oncology
    • RX
    • Studies
  • 2 minute read

In patients at intermediate risk for colorectal cancer, colonoscopy is recommended by most European and American organizations as a screening examination starting at age 50 at intervals not exceeding 10 years. But how do patients outside the screening population, i.e. younger affected individuals, fare? Although cancer cases are increasing in this group, outcomes are currently poorly understood. A recently published cohort study provides new insights.

The US study from the setting of the renowned Mayo Clinic had a population-based retrospective cohort design. The sample was registry data (SEER database, 1998-2011) from a total of 258 024 colorectal cancer patients, 15% of whom were under 50 years of age (mean age 42.5).

The younger patients were more likely to have advanced tumors at the time of diagnosis. The relative risk for regional extension was significantly increased by 30% compared with older patients, and that for distant metastases by as much as 50%. Despite these poor outcomes, younger sufferers survived the disease longer than older sufferers (significant risk reduction for disease-specific death by 23%; HR 0.77; p<0.001). Radiation was used significantly more often in younger patients (53% vs. 48% probability), and surgery was performed more often on the primary tumor for distant metastases in them (72% vs. 63%; p<0.001).

Young patients not forgotten

Patients who develop colorectal cancer under the age of 50 are more likely to present with advanced disease, but are treated more aggressively and subsequently survive longer than their older counterparts, the study concluded. The key question now is: Should colorectal cancer screening start earlier? In any case, more attention needs to be paid to the increasing number of patients under 50 years of age. Warning symptoms such as change in bowel function and blood in the stool should be taken more seriously to prevent the common delay in diagnosis at a young age, according to the authors.

Currently, colorectal cancer is predominantly considered a disease of the elderly. Although earlier screening is already recommended for certain risk factors and family history, many physicians still do not comply with this recommendation, according to the authors.

Source: Abdelsattar ZM, et al: Colorectal cancer outcomes and treatment patterns in patients too young for average-risk screening. Cancer 2016 Jan 25. doi: 10.1002/cncr.29716 [Epub ahead of print].

 

InFo ONCOLOGY & HEMATOLOGY 2016; 4(4): 3.

Autoren
  • Andreas Grossmann
Publikation
  • InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
  • colonoscopy
  • Colorectal cancer
Previous Article
  • Whole brain irradiation or stereotaxy?

Options for radiotherapy in brain metastases

  • Education
  • Neurology
  • Oncology
  • Radiology
  • RX
  • Studies
View Post
Next Article
  • What helps with fatigue and exhaustion?

Therapy of tumor fatigue

  • Education
  • General Internal Medicine
  • Oncology
  • RX
View Post
You May Also Like
View Post
  • 6 min
  • Autoimmune Liver Diseases

Innovative Treatment Approaches for PBC, PSC, and AIH: What’s New?

    • RX
    • Congress Reports
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Studies
View Post
  • 8 min
  • Myelofibrosis

Mutations and Molecular Diagnostics in Treatment Decisions

    • RX
    • Education
    • Hematology
    • Oncology
    • Studies
View Post
  • 5 min
  • Psoriasis in the Age of Precision Medicine

Systemic Therapy for Patients with Comorbidities: What Is the Best Choice?

    • RX
    • Cardiology
    • Congress Reports
    • Dermatology and venereology
    • Gastroenterology and Hepatology
    • Nutrition
    • Rheumatology
    • Studies
View Post
  • 13 min
  • The AMALFI study and the limits of digital screening for atrial fibrillation

Remote monitoring for atrial fibrillation: lots of detection, little stroke prevention?

    • RX
    • Cardiology
    • Education
    • Studies
View Post
  • 4 min
  • MASH

Pharmacotherapies as “Game Changers”—What Are the Upcoming Challenges?

    • RX
    • Congress Reports
    • Endocrinology and Diabetology
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Studies
View Post
  • 13 min
  • Obesity Treatment

Oral GLP-1 Therapies: ATTAIN-1 and OASIS-4—The Next Leap Forward

    • RX
    • Education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Nutrition
    • Prevention and health care
    • Studies
View Post
  • 5 min
  • Older patients with atopic dermatitis

Why the Use of Biologics Is Recommended

    • RX
    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • Studies
View Post
  • 4 min
  • Disorders of the Gut-Brain Interaction

Peppermint-Caraway Oil Supplement Proves Effective in Phase IV Trial

    • RX
    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Pharmaceutical medicine
    • Pharmacology and toxicology
    • Phytotherapy
    • Studies
  • IBD matters

    Zum Thema
Top CME content
  • 1
    Update on Anti-Rheumatic Medications
  • 2
    Psychiatry versus Neuro-Oncology: Diagnostic Pitfalls
  • 3
    Focus on preventive care options
  • 4
    Inflammation as a Treatment Goal in Its Own Right
  • 5
    Personalized Treatment Before a Planned Pregnancy

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.